Adults with add
Pro Research Analysisby 
Searched over 200M research papers
Understanding and Managing Attention Deficit Disorder (ADD) in Adults
Prevalence and Recognition of ADD in Adults
Attention Deficit Disorder (ADD), also known as Attention-Deficit/Hyperactivity Disorder (ADHD), is increasingly recognized as a legitimate and prevalent disorder among adults. Despite this, there remains a significant misunderstanding about its nature. ADD/ADHD is fundamentally a cognitive disorder characterized by impaired executive functions (EFs), which are crucial for self-management and executing daily tasks2. Studies indicate that a substantial proportion of children diagnosed with ADHD continue to exhibit symptoms into adulthood, with estimates ranging from one-third to one-half4.
Clinical Profile and Comorbidities
Adults with ADD often present with a complex clinical profile that includes a high prevalence of psychiatric comorbidities. For instance, a study on Canadian adults found that those with self-reported ADD/ADHD had significantly higher rates of major depressive disorder, bipolar disorders, generalized anxiety disorder, and substance use disorders compared to controls3. Similarly, another study reported that a majority of adults with ADHD had additional DSM-III-R diagnoses, including generalized anxiety disorder, alcohol abuse, drug abuse, dysthymic disorder, and cyclothymic disorder4.
Diagnostic Challenges and Misdiagnosis
Diagnosing ADD in adults can be challenging due to its overlap with other affective temperaments, such as cyclothymia. Misdiagnosis is common, and the use of amphetamines in treatment can sometimes exacerbate mood and anxiety symptoms in individuals with these temperaments9. Accurate diagnosis requires a thorough clinical assessment, often supported by self-rating scales and structured interviews10.
Treatment Approaches
Pharmacological Interventions
Pharmacological treatment for ADD in adults typically includes stimulants and antidepressants. Stimulants are well-supported by evidence and can benefit up to 60% of individuals with ADD10. However, the effectiveness of stimulant therapy alone can vary. For example, a study comparing venlafaxine (an antidepressant) with stimulant therapy found that venlafaxine monotherapy and combination therapy (stimulant plus antidepressant) were more effective in reducing both ADD and depressive symptoms compared to stimulant therapy alone6.
Non-Pharmacological Interventions
Non-pharmacological treatments, such as Dialectical Behavior Therapy Skills Training (DBT-ST), have also been explored. A feasibility trial in Latin America showed that DBT-ST had high attendance and completion rates, although it did not significantly outperform treatment as usual in reducing ADHD symptoms1. This suggests that while DBT-ST is feasible, its efficacy as an add-on treatment needs further investigation.
Conclusion
ADD in adults is a complex and often misunderstood disorder that requires careful diagnosis and a multifaceted treatment approach. The presence of significant psychiatric comorbidities and the potential for misdiagnosis highlight the need for comprehensive clinical assessments. Both pharmacological and non-pharmacological treatments can be effective, but their success may vary depending on individual patient profiles. Recognizing and addressing ADD in adults is crucial for improving their quality of life and overall functioning.
Sources and full results
Most relevant research papers on this topic